The deterioration of chronic heart failure – so-called worsening heart failure (WHF) – is no longer solely an acute event, but an expression of complex, often repetitive pathophysiological dynamics. Despite improved pharmacotherapy, earlier diagnosis and more sophisticated monitoring, the hospitalization rate remains high and mortality within the first year after discharge is a cause for concern. New data show that WHF is not only the final stage of advanced heart failure, but is often triggered by treatable mechanisms: Volume shifts, inadequate neurohormone blockade, inflammatory or metabolic triggers and inadequate adherence to therapy.
You May Also Like
- Treatment of type 2 diabetes: paradigm shift continues
Cardiorenal organ protection is increasingly coming to the fore
- Semaglutide and tirzepatide in HFpEF and T2D/obesity
Prospect of improved cardiovascular prognosis
- Case report: alveolar sarcoidosis
Acute hypoxemic respiratory failure as initial manifestation
- "Swiss Health Care Atlas"
Supply situation in Switzerland: Update
- Lung cancer
Multidisciplinary teams in oncology
- Adrenogenital syndrome
Clinical care from birth to adulthood
- Psoriasis: System therapies in everyday practice
Current real-world data at a glance
- Omega-3 fatty acids for obesity and type 2 diabetes